MartucciAZanottoECurtoniA, et al. The performance of an ophthalmic solution containing Poloxamer 407 and Polyquaternium 133 in reducing conjunctival bacterial load in patients receiving cataract surgery, a randomized trial. Eur J Ophthalmol. Epub ahead of print 9 September 2025: 11206721251375236. doi:10.1177/11206721251375236. PMID: 40924815.
2.
ChomchalaoPSaelimNLamlertthonS, et al.A potential thermosensitive poloxamer 407-based in situ hydrogel containing moxifloxacin loaded silk fibroin nanoparticles for prolonged ocular delivery. J Drug Deliv Sci Technol2024; 99: 105988. doi:10.1016/j.jddst.2024.105988.
3.
lmeidaHAmaralMHLobãoP,et al.Applications of poloxamers in ophthalmic pharmaceutical formulations: an overview. Expert Opin Drug Deliv2013; 10: 1223–1237. doi:10.1517/17425247.2013.796360.